https://www.sec.gov/Archives/edgar/data/1357878/000147237517000097/form10-12ga.htm
On Nov. 23,2021 Peptide Technologies Inc. filed a Pre 14C to change the company's name to Regenerex Pharma Inc.
https://www.sec.gov/Archives/edgar/data/1357878/000147237521000143/pre14c.htm
From Sept. 5,2017 the company filed all Financial reports to EDGAR.
https://www.sec.gov/Archives/edgar/data/1357878/000147237517000097/form10-12ga.htm
From conjecture the company must have asked FINRA to reinstate the stock under the name Regenerex Pharma Inc., ticker RGPX. We don't know if a Market Maker submitted a FORM 211 to FINRA to represent the stock. We'll know the answer if/when we see the stock trade on the OTC.
To bite the worm of incite is to bite the HOOK of the antagonist . They win .
Recent RGPX News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/05/2024 08:07:59 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM